Health authorities in England are launching a vaccination campaign targeting young people at elevated risk of meningitis B infection. The initiative comes in response to an outbreak detected in Kent that resulted in 29 confirmed or suspected cases and two deaths. Nearly 90,000 doses have already been administered, with an additional 135,000 doses scheduled for the coming weeks.
Eligible recipients include 17 and 18-year-olds in sixth form, as well as students under age 25 entering residential university or further education settings for the first time this autumn. Individuals born between 1 September 2007 and 31 August 2008, and those born on or after 21 July 2001 who are beginning higher education, qualify for the program. International students and those from other UK nations attending institutions in England are also eligible. The vaccine requires two doses administered at least 28 days apart for full protection.
According to NHS England, first-year university students face a risk approximately seven times higher than peers not attending university. The heightened danger stems from increased social mixing and shared residential accommodations. Meningitis B can cause serious complications including meningitis, sepsis, and potentially life-altering disabilities such as hearing loss or amputations. The infection spreads through close contact such as kissing or sharing items.
Vaccinations can be accessed through high street pharmacies across England. Eligible 17 and 18-year-olds may book appointments via the NHS National Booking Service if registered with a general practitioner. Walk-in services are available at participating pharmacies for those meeting age and enrollment criteria without requiring GP registration. Side effects are typically mild, including injection site reactions or temporary fever, though serious adverse effects remain rare.
Vaccine experts have suggested the government consider routinely offering the MenB vaccine to all teenagers around age 15, though final decisions rest with ministers in each nation. Currently, the MenACWY vaccine covering different bacterial strains is routinely offered to 14-year-olds, while the MenB vaccine was added to the childhood immunization program only for infants born on or after 1 July 2015.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI